The Food and Drug Administration (FDA) is hosting a meeting next week to help inform cannabis researchers and cultivators about opportunities to protect their proprietary information and promote studies into the plant.
The webinar, which is taking place on Wednesday, will encourage cannabis-based drug developers and growers to use “drug master files,” or DMFs, which “are submissions to FDA used to provide confidential, detailed information about facilities, processes, or articles used in the manufacturing, processing, packaging, and storing of human drug products.”
In essence, a DMF is a secure method of transmitting private documents that could help supplement various proposals to the agency such as Investigational New Drug Applications (INDs) without risking competitors getting their hands on trade secrets.
Participants in the event “will learn how DMFs might be able to help address their concerns related to the disclosure of potentially proprietary information,” FDA said in a notice.
Read more at marijuanamoment.net
